BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10907612)

  • 1. [Flupenthixol--a partial atypical neuroleptic?].
    Kühn KU; Meyer K; Maier W
    Fortschr Neurol Psychiatr; 2000 Apr; 68 Suppl 1():S38-41. PubMed ID: 10907612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The atypical neuroleptic concept].
    Azorin JM; Dassa D; Jalfre M
    Encephale; 1992 Sep; 18 Spec No 3():453-7. PubMed ID: 1364079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
    Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
    Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amisulpride: limbic specificity and the mechanism of antipsychotic atypicality.
    Möller HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1101-11. PubMed ID: 14642970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flupentixol.
    Nurs Times; 2006 Jul 4-10; 102(27):31. PubMed ID: 16850705
    [No Abstract]   [Full Text] [Related]  

  • 9. Receptor pharmacology of neuroleptics: relation to clinical effects.
    Richelson E
    J Clin Psychiatry; 1999; 60 Suppl 10():5-14. PubMed ID: 10340682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.
    Singh AN; Barlas C; Singh S; Franks P; Mishra RK
    J Psychiatry Neurosci; 1996 Jan; 21(1):29-35. PubMed ID: 8580115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New antipsychotic agents].
    Brochier T
    Rev Prat; 1994 Nov; 44(17):2312-5. PubMed ID: 7984938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the treatment of schizophrenia: focus on serotonin (5-HT)(1A) receptors.
    Millan MJ
    J Pharmacol Exp Ther; 2000 Dec; 295(3):853-61. PubMed ID: 11082417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current concepts of the effects of neuroleptics].
    Kostowski W; Płaźnik A
    Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
    Harrison PJ
    Br J Psychiatry Suppl; 1999; (38):12-22. PubMed ID: 10884896
    [No Abstract]   [Full Text] [Related]  

  • 16. Does loxapine have "atypical" properties? Clinical evidence.
    Glazer WM
    J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is amisulpride an 'atypical' atypical antipsychotic agent?
    Lecrubier Y
    Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP
    J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
    J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical neuroleptics in the treatment of early onset schizophrenia.
    Masi G
    Panminerva Med; 1997 Sep; 39(3):215-21. PubMed ID: 9360425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.